Cel-Sci Overview
Compare Cel-Sci's DCF valuation ($0.39) to today's market price.
Get informed when a big investor buys or sells
+ Follow$0.39
Overvalued by 77.2% based on the discounted cash flow analysis.
The latest DCF fair value for CVM is $0.39. Investors often review this figure alongside Cel-Sci's historical trend and sector peers before judging valuation or financial health.
A DCF fair value of $0.39 for Cel-Sci suggests the stock may be overvalued by roughly 77.2% at today's price. That does not mean the market is 'wrong'; it means the model's cash-flow assumptions imply a different intrinsic value. Stress-test the estimate by comparing it with historical valuation ranges and peer multiples.
After noting CVM's DCF fair value ($0.39), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Cel-Sci's DCF fair value against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
